Patients with uveitis treated with repository corticotropin injection experienced a reduction in uveitis medication use and improvement in vision, according to a study.
The retrospective review of medical records included 91 patients with uveitis. Twenty-one patients had mild or no visual impairment, 48 had moderate visual impairment, and 21 had severe visual impairment; severity was not known in one patient. No patients were blind before repository corticotropin injection (RCI).
RCI dosing regimens and course of treatment were different for each patient. Patients had used a mean of 2.5